Skip to main content

The future of branding in the pharmaceutical industry

  • Chapter
Brand Medicine
  • 123 Accesses

Abstract

One could make the argument that pharmaceutical marketers have not produced any brands that occupy a consistent and compelling mindshare over time as consumer marketers have done. There is no pharmaceutical equivalent to Coke, ‘the number one cola’ for decades; to BMW, ‘the ultimate driving machine’; or to Burger King, ‘the best place to get a big burger’.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Copyright information

© 2001 Tom Harrison

About this chapter

Cite this chapter

Harrison, T. (2001). The future of branding in the pharmaceutical industry. In: Blackett, T., Robins, R. (eds) Brand Medicine. Palgrave Macmillan, London. https://doi.org/10.1057/9780230522510_19

Download citation

Publish with us

Policies and ethics